Technical Analysis for ZCOR - Egalet Corp

Grade Last Price % Change Price Change
grade D 2.2 -6.78% -0.1600
ZCOR closed down 6.78 percent on Tuesday, June 18, 2019, on 3 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical ZCOR trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -6.78%
Hot IPO Pullback Bullish Swing Setup -6.78%
Narrow Range Bar Range Contraction -6.78%

Older signals for ZCOR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.
RTT Euphoriants Pharmaceutical Psychoactive Drugs Chemical Compounds Morphinans Heroin Opioids Morphine Oxycodone Acute And Chronic Pain Analgesic Pain Products Alternative Treatments Hydrocodone Immediate Release Oxycodone Product Morphine Product Nasal Spray Short Term Management Sprix Nasal Spray
Is ZCOR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.0
52 Week Low 2.19
Average Volume 33,082
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 2.5708
10-Day Moving Average 2.4765
Average True Range 0.119
ADX 0.0
+DI 17.9569
-DI 59.546
Chandelier Exit (Long, 3 ATRs ) 2.643
Chandelier Exit (Short, 3 ATRs ) 2.547
Upper Bollinger Band 2.8979
Lower Bollinger Band 2.2437
Percent B (%b) -0.07
BandWidth 25.447332
MACD Line -0.1415
MACD Signal Line -0.0738
MACD Histogram -0.0677
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.2900
Resistance 3 (R3) 2.2967 2.2733 2.2750
Resistance 2 (R2) 2.2733 2.2504 2.2700 2.2700
Resistance 1 (R1) 2.2367 2.2363 2.2250 2.2300 2.2650
Pivot Point 2.2133 2.2133 2.2075 2.2100 2.2133
Support 1 (S1) 2.1767 2.1904 2.1650 2.1700 2.1350
Support 2 (S2) 2.1533 2.1763 2.1500 2.1300
Support 3 (S3) 2.1167 2.1533 2.1250
Support 4 (S4) 2.1100